Opening book details…
About this Medicine article
1168PPhase I/II study of CTLA-4 inhibitor AGEN1884 + PD-1 Inhibitor AGEN2034 in patients with advanced/refractory solid tumors, with expansion into 2L cervical cancer and solid tumors by Coward, J; Lemech, C; Meniawy, T; Dupont, C D; Gonzalez, A M; Lim, M; Savitsky, D; Carini, M; Hu, S; Shebanova, O; Dow, E; Ortuzar, W; Buell, J S; Stein, R B; Youssoufian, H is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Coward, J; Lemech, C; Meniawy, T; Dupont, C D; Gonzalez, A M; Lim, M; Savitsky, D; Carini, M; Hu, S; Shebanova, O; Dow, E; Ortuzar, W; Buell, J S; Stein, R B; Youssoufian, H
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2018
- Field
- Medicine (Health Sciences)